Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Announcement Summary

For personal use only

Entity name

IMAGION BIOSYSTEMS LIMITED

Date of this announcement

Tuesday February 22, 2022

The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

Total number of +securities to be issued/transferred

Total number of

ASX +security

+securities to be

code

Security description

issued/transferred

Issue date

New class - code

OPTION EXPIRING VARIOUS DATES EX

1,000,000

17/02/2022

to be confirmed

$0.0679

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted

1 / 9

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

IMAGION BIOSYSTEMS LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2

Registered number type

Registration number

ACN

616305027

1.3

ASX issuer code

IBX

1.4 The announcement is

New announcement

1.5

Date of this announcement

22/2/2022

Notification of Issue, Conversion or Payment up of Unquoted

2 / 9

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

For personal use only

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

does not have an existing ASX security code ("new class")

Notification of Issue, Conversion or Payment up of Unquoted

3 / 9

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B

only

ASX +security code

+Security description

New class - code to be confirmed

OPTION EXPIRING VARIOUS DATES EX $0.0679

+Security type

ISIN code

Options

use

Date the +securities the subject of this notification were issued

17/2/2022

Will all the +securities issued in this class rank equally in all respects from their issue date?

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate?

personal

No

Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under

listing rule 6.1?

Yes

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being

issued.

A summary of the terms of the Employee Incentive Scheme were provided in the Notice of Annual General Meeting

announced to the ASX on 19 June 2020https://www.asx.com.au/asxpdf/20200619/pdf/44jsf59t4j96kz.pdf

Options Details

+Security currency

Exercise price

Expiry date

AUD - Australian Dollar

AUD 0.06790000

31/1/2030

For

Details of the existing class of +security that will be issued upon exercise or conversion of this new class of

company option

Other

Description

One fully paid ordinary share (ASX:IBX)

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

A summary of the terms of the Employee Incentive Scheme were provided in the Notice of Annual General Meeting announced to the ASX on 19 June 2020 https://www.asx.com.au/asxpdf/20200619/pdf/44jsf59t4j96kz.pdf

Notification of Issue, Conversion or Payment up of Unquoted

4 / 9

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Any other information the entity wishes to provide about the +securities the subject of this notification

Issue details

For personal use only

Number of +securities

1,000,000

Notification of Issue, Conversion or Payment up of Unquoted

5 / 9

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Imagion Biosystems Ltd. published this content on 21 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 February 2022 21:30:01 UTC.